Table I.
Association between SNHG12 expression and clinicopathological characteristics of gastric cancer patients.
| SNHG12 levels | ||||
|---|---|---|---|---|
| Parameter | Cases (n=56) | Low (n=31) | High (n=25) | P-value |
| Age (years) | 1.000 | |||
| ≤60 | 19 | 11 | 8 | |
| >60 | 37 | 20 | 17 | |
| Sex | 0.278 | |||
| Male | 34 | 21 | 13 | |
| Female | 22 | 10 | 12 | |
| Tumor size (cm) | 0.035 | |||
| ≤5 | 27 | 19 | 8 | |
| >5 | 29 | 12 | 17 | |
| Differentiation | 0.057 | |||
| Well and moderately | 33 | 22 | 11 | |
| Poor | 23 | 9 | 14 | |
| Node metastasis | 0.006 | |||
| Present | 48 | 23 | 25 | |
| Absent | 8 | 8 | 0 | |
| Clinical stage | 0.045 | |||
| I–II | 17 | 13 | 4 | |
| III–IV | 39 | 18 | 21 | |
SNHG12, small nucleolar RNA host gene 12.